Clinical Trials Directory

Trials / Completed

CompletedNCT01238263

Autologous Serum Skin Testing in Patients With Atopic Dermatitis Autologous Serum Skin Testing in Patients With Atopic Dermatitis

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Yuzuncu Yil University · Academic / Other
Sex
All
Age
1 Year – 45 Years
Healthy volunteers
Accepted

Summary

Recently, IgE-type autoantibodies against self proteins have been detected in the serum of the atopic dermatitis patients. The role of this IgE autoantibodies involved in the pathogenesis of atopic dermatitis is not known, yet. But, there may be a correlation between the severity of the disease and the serum levels of this autoantibodies. The autologous serum skin testing is applied to both atopic dermatitis patients and healthy control and the results are estimated in this study.The investigators detected 70% positive autologous serum skin testing in atopic dermatitis patients and test positivity was higher in patients with atopy history, moderately severe disease calculated by SCORAD index and high serum IgE levels.

Conditions

Timeline

Start date
2009-04-01
Primary completion
2010-06-01
Completion
2010-08-01
First posted
2010-11-10
Last updated
2010-11-10

Source: ClinicalTrials.gov record NCT01238263. Inclusion in this directory is not an endorsement.